Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Median raphe controls acquisition of negative experience in the mouse.

Szőnyi A, Zichó K, Barth AM, Gönczi RT, Schlingloff D, Török B, Sipos E, Major A, Bardóczi Z, Sos KE, Gulyás AI, Varga V, Zelena D, Freund TF, Nyiri G.

Science. 2019 Nov 29;366(6469). pii: eaay8746. doi: 10.1126/science.aay8746.

PMID:
31780530
2.

Formulation and Characterization of Aceclofenac-Loaded Nanofiber Based Orally Dissolving Webs.

Sipos E, Kósa N, Kazsoki A, Szabó ZI, Zelkó R.

Pharmaceutics. 2019 Aug 17;11(8). pii: E417. doi: 10.3390/pharmaceutics11080417.

3.

Experimental Investigation of Damage Formation in Planar Fibrous Networks During Stretching.

Sipos E, Kaneko T, Zrinyi M.

Sci Rep. 2019 Feb 26;9(1):2816. doi: 10.1038/s41598-019-39460-3.

4.

Corrigendum: RNA-DNA hybrid (R-loop) immunoprecipitation mapping: an analytical workflow to evaluate inherent biases.

Halász L, Karányi Z, Boros-Oláh B, Kuik-Rózsa T, Sipos É, Nagy É, Mosolygó-L Á, Mázló A, Rajnavölgyi É, Halmos G, Székvölgyi L.

Genome Res. 2019 Jan;29(1):157. doi: 10.1101/gr.246652.118. No abstract available.

5.

Modelling posttraumatic stress disorders in animals.

Török B, Sipos E, Pivac N, Zelena D.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 2;90:117-133. doi: 10.1016/j.pnpbp.2018.11.013. Epub 2018 Nov 20. Review.

PMID:
30468906
6.

Experimental therapy of doxorubicin resistant human uveal melanoma with targeted cytotoxic luteinizing hormone-releasing hormone analog (AN-152).

Oláh G, Dobos N, Vámosi G, Szabó Z, Sipos É, Fodor K, Harda K, Schally AV, Halmos G.

Eur J Pharm Sci. 2018 Oct 15;123:371-376. doi: 10.1016/j.ejps.2018.08.002. Epub 2018 Aug 2.

PMID:
30076951
7.

Effect of Vipera ammodytes ammodytes Snake Venom on the Human Cytokine Network.

Boda F, Banfai K, Garai K, Curticapean A, Berta L, Sipos E, Kvell K.

Toxins (Basel). 2018 Jun 25;10(7). pii: E259. doi: 10.3390/toxins10070259.

8.

Behavioural alterations and morphological changes are attenuated by the lack of TRPA1 receptors in the cuprizone-induced demyelination model in mice.

Bölcskei K, Kriszta G, Sághy É, Payrits M, Sipos É, Vranesics A, Berente Z, Ábrahám H, Ács P, Komoly S, Pintér E.

J Neuroimmunol. 2018 Jul 15;320:1-10. doi: 10.1016/j.jneuroim.2018.03.020. Epub 2018 Apr 6.

PMID:
29759134
9.

Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines.

Sipos E, Dobos N, Rozsa D, Fodor K, Olah G, Szabo Z, Szekvolgyi L, Schally AV, Halmos G.

Onco Targets Ther. 2018 Feb 22;11:933-941. doi: 10.2147/OTT.S148174. eCollection 2018.

10.

Task Division within the Prefrontal Cortex: Distinct Neuron Populations Selectively Control Different Aspects of Aggressive Behavior via the Hypothalamus.

Biro L, Sipos E, Bruzsik B, Farkas I, Zelena D, Balazsfi D, Toth M, Haller J.

J Neurosci. 2018 Apr 25;38(17):4065-4075. doi: 10.1523/JNEUROSCI.3234-17.2018. Epub 2018 Feb 27.

11.

Quantitative Comparison of Primary Cilia Marker Expression and Length in the Mouse Brain.

Sipos É, Komoly S, Ács P.

J Mol Neurosci. 2018 Mar;64(3):397-409. doi: 10.1007/s12031-018-1036-z. Epub 2018 Feb 20.

PMID:
29464516
12.

Application of SeDeM expert systems in preformulation studies of pediatric ibuprofen ODT tablets.

Sipos E, Oltean AR, Szabó ZI, Rédai EM, Nagy GD.

Acta Pharm. 2017 Jun 27;67(2):237-246. doi: 10.1515/acph-2017-0017.

PMID:
28590910
13.

Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.

Sipos E, Hegyi K, Treszl A, Steiber Z, Mehes G, Dobos N, Fodor K, Olah G, Szekvolgyi L, Schally AV, Halmos G.

Oncol Rep. 2017 Apr;37(4):1927-1934. doi: 10.3892/or.2017.5496. Epub 2017 Mar 8.

14.

RNA-DNA hybrid (R-loop) immunoprecipitation mapping: an analytical workflow to evaluate inherent biases.

Halász L, Karányi Z, Boros-Oláh B, Kuik-Rózsa T, Sipos É, Nagy É, Mosolygó-L Á, Mázló A, Rajnavölgyi É, Halmos G, Székvölgyi L.

Genome Res. 2017 Jun;27(6):1063-1073. doi: 10.1101/gr.219394.116. Epub 2017 Mar 24. Erratum in: Genome Res. 2019 Jan;29(1):157.

15.

TRPA1 deficiency is protective in cuprizone-induced demyelination-A new target against oligodendrocyte apoptosis.

Sághy É, Sipos É, Ács P, Bölcskei K, Pohóczky K, Kemény Á, Sándor Z, Szőke É, Sétáló G Jr, Komoly S, Pintér E.

Glia. 2016 Dec;64(12):2166-2180. doi: 10.1002/glia.23051. Epub 2016 Aug 29.

PMID:
27568827
16.

Structural and functional alterations in the prefrontal cortex after post-weaning social isolation: relationship with species-typical and deviant aggression.

Biro L, Toth M, Sipos E, Bruzsik B, Tulogdi A, Bendahan S, Sandi C, Haller J.

Brain Struct Funct. 2017 May;222(4):1861-1875. doi: 10.1007/s00429-016-1312-z. Epub 2016 Sep 23.

PMID:
27664119
17.

Preparation and characterization of nanofibrous sheets for enhanced oral dissolution of nebivolol hydrochloride.

Sipos E, Szabó ZI, Rédai E, Szabó P, Sebe I, Zelkó R.

J Pharm Biomed Anal. 2016 Sep 10;129:224-228. doi: 10.1016/j.jpba.2016.07.004. Epub 2016 Jul 5.

PMID:
27433987
18.

Study of the effect of formulation variables on the characteristics of combination tablets containing enalapril maleate and indapamide as active substances using experimental design.

Szabó ZI, Székely-Szentmiklósi B, Deák B, Székely-Szentmiklósi I, Kovács B, Zöldi K, Sipos E.

Acta Pharm. 2016 Jun 1;66(2):191-206. doi: 10.1515/acph-2016-0019.

PMID:
27279063
19.

Enduring abolishment of remote but not recent expression of conditioned fear by the blockade of calcium-permeable AMPA receptors before extinction training.

Zelena D, Mikics É, Balázsfi D, Varga J, Klausz B, Urbán E, Sipos E, Biró L, Miskolczi C, Kovács K, Ferenczi S, Haller J.

Psychopharmacology (Berl). 2016 Jun;233(11):2065-2076. doi: 10.1007/s00213-016-4255-4. Epub 2016 Mar 28.

PMID:
27020785
20.

Comparative in vitro biological evaluation of daunorubicin containing GnRH-I and GnRH-II conjugates developed for tumor targeting.

Szabó I, Bősze S, Orbán E, Sipos É, Halmos G, Kovács M, Mező G.

J Pept Sci. 2015 May;21(5):426-35. doi: 10.1002/psc.2775. Epub 2015 Apr 24.

PMID:
25908176
21.

Simultaneous quantification of related substances of perindopril tert-butylamine using a novel stability indicating liquid chromatographic method.

Szabó ZI, Réti ZZ, Gagyi L, Kis EL, Sipos E.

J Chromatogr Sci. 2015 Mar;53(3):424-30. doi: 10.1093/chromsci/bmu223. Epub 2015 Jan 22.

PMID:
25616989
22.

The role of co-spray-drying procedure in the preformulation of intranasal propranolol hydrochloride.

Ambrus R, Gergely M, Zvonar A, Szabó-Révész P, Sipos E.

Acta Chim Slov. 2014;61(3):601-7.

PMID:
25286216
23.

[Heart rate variability is significantly reduced in non-diabetic patients with hypertension].

Nagy K, Sipos E, El Hadj Othmane T.

Orv Hetil. 2014 Jun 1;155(22):865-70. doi: 10.1556/OH.2014.29886. Hungarian.

PMID:
24860051
24.

Development of new formulation and its evaluation by capillary electrophoresis of tablets containing tramadol hydrochloride and paracetamol.

Ciurba A, Hancu G, Cojocea LM, Sipos E, Todoran N.

Pharm Dev Technol. 2014 Nov;19(7):833-8. doi: 10.3109/10837450.2013.836219. Epub 2013 Sep 12.

PMID:
24028179
25.

Enhanced cellular uptake and in vitro antitumor activity of short-chain fatty acid acylated daunorubicin-GnRH-III bioconjugates.

Hegedüs R, Manea M, Orbán E, Szabó I, Kiss E, Sipos E, Halmos G, Mező G.

Eur J Med Chem. 2012 Oct;56:155-65. doi: 10.1016/j.ejmech.2012.08.014. Epub 2012 Aug 23.

PMID:
22967796
26.

Changes in PACAP immunoreactivity in human milk and presence of PAC1 receptor in mammary gland during lactation.

Csanaky K, Banki E, Szabadfi K, Reglodi D, Tarcai I, Czegledi L, Helyes Z, Ertl T, Gyarmati J, Szanto Z, Zapf I, Sipos E, Shioda S, Tamas A.

J Mol Neurosci. 2012 Nov;48(3):631-7. Epub 2012 Apr 27.

PMID:
22539193
27.

3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility.

Lacava C, Michalek-Sauberer A, Kraft B, Sgaragli G, Sipos E, Höller C, Kress HG, Fusi F, Weigl LG.

Pharmacol Res. 2012 Jul;66(1):80-7. doi: 10.1016/j.phrs.2012.03.012. Epub 2012 Mar 28.

PMID:
22480578
28.

Proinflammatory adhesion molecules facilitate polychlorinated biphenyl-mediated enhancement of brain metastasis formation.

Sipos E, Chen L, András IE, Wrobel J, Zhang B, Pu H, Park M, Eum SY, Toborek M.

Toxicol Sci. 2012 Apr;126(2):362-71. doi: 10.1093/toxsci/kfr349. Epub 2012 Jan 12.

29.

Patient satisfaction and postoperative pain with different postoperative therapy regimens after standardized cataract surgery: a randomized intraindividual comparison.

Sipos E, Stifter E, Menapace R.

Int Ophthalmol. 2011 Dec;31(6):453-60. doi: 10.1007/s10792-011-9497-x. Epub 2012 Jan 10.

PMID:
22231764
30.

Intranasal delivery of human beta-amyloid peptide in rats: effective brain targeting.

Sipos E, Kurunczi A, Fehér A, Penke Z, Fülöp L, Kasza A, Horváth J, Horvát S, Veszelka S, Balogh G, Kürti L, Eros I, Szabó-Révész P, Párducz A, Penke B, Deli MA.

Cell Mol Neurobiol. 2010 Apr;30(3):405-13. doi: 10.1007/s10571-009-9463-6. Epub 2009 Oct 6.

PMID:
19806448
31.

[Stability of some medicinal solutions with captopril].

Imre S, Vancea S, Muntean DL, Sipos E, Cociş A, Avrigeanu V, Mircia E.

Rev Med Chir Soc Med Nat Iasi. 2008 Jul-Sep;112(3):848-55. Romanian.

PMID:
20201280
32.

[Pumpless extracorporeal lung assist].

Göbölös L, Hejjel L, Imre J, Lindenmayer-G R, Wiebe K, Foltan M, Thrum A, Ugocsai P, Tóth Z, Farkasfalvi K, Sipos E, Kiss R, Gyorimolnár I, Philipp A.

Orv Hetil. 2008 Jun 29;149(26):1233-6. doi: 10.1556/OH.2008.28380. Hungarian.

PMID:
18565818
33.

Examination of resistance of potato genotypes to Erwinia ssp.

Kállai M, Csitári G, Sipos E, Polgár Z.

Commun Agric Appl Biol Sci. 2007;72(4):813-7.

PMID:
18396815
34.

Soft-rot resistance test of in vitro preselected stress tolerant potato genotypes.

Sipos E, Kállai M, Csitári G, Polgár Z.

Commun Agric Appl Biol Sci. 2007;72(4):751-6. No abstract available.

PMID:
18396805
35.

[The principles of minimal extracorporeal circulation and its uses].

Göbölös L, Hejjel L, Lindenmayer-G R, Wiebe K, Philipp A, Foltan M, Ziegler S, Imre J, Sipos E, Gyorimolnár I, Papp L.

Orv Hetil. 2007 Nov 18;148(46):2167-71. Review. Hungarian.

PMID:
17988973
36.

Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.

Sipos E, Kurunczi A, Kasza A, Horváth J, Felszeghy K, Laroche S, Toldi J, Párducz A, Penke B, Penke Z.

Neuroscience. 2007 Jun 15;147(1):28-36. Epub 2007 May 17.

PMID:
17499931
37.

Diagnostic significance of HLA-DQ typing in patients with previous coeliac disease diagnosis based on histology alone.

Kapitány A, Tóth L, Tumpek J, Csípo I, Sipos E, Woolley N, Partanen J, Szegedi G, Oláh E, Sipka S, Korponay-Szabó IR.

Aliment Pharmacol Ther. 2006 Nov 1;24(9):1395-402.

38.

Local anti-angiogenic brain tumor therapies.

Sipos EP, Brem H.

J Neurooncol. 2000 Oct-Nov;50(1-2):181-8. Review.

PMID:
11245278
39.

L-buthionine sulfoximine potentiates the antitumor effect of 4-hydroperoxycyclophosphamide when administered locally in a rat glioma model.

Sipos EP, Witham TF, Ratan R, Burger PC, Baraban J, Li KW, Piantadosi S, Brem H.

Neurosurgery. 2001 Feb;48(2):392-400.

PMID:
11220384
40.

Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculature.

Sills AK Jr, Williams JI, Tyler BM, Epstein DS, Sipos EP, Davis JD, McLane MP, Pitchford S, Cheshire K, Gannon FH, Kinney WA, Chao TL, Donowitz M, Laterra J, Zasloff M, Brem H.

Cancer Res. 1998 Jul 1;58(13):2784-92.

41.

Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain.

Fung LK, Ewend MG, Sills A, Sipos EP, Thompson R, Watts M, Colvin OM, Brem H, Saltzman WM.

Cancer Res. 1998 Feb 15;58(4):672-84.

42.

Implantable biodegradable polymers for IUdR radiosensitization of experimental human malignant glioma.

Williams JA, Dillehay LE, Tabassi K, Sipos E, Fahlman C, Brem H.

J Neurooncol. 1997 May;32(3):181-92.

PMID:
9049879
43.

Primary intracerebral small-cell osteosarcoma in an adolescent girl: report of a case.

Sipos EP, Tamargo RJ, Epstein JI, North RB.

J Neurooncol. 1997 Apr;32(2):169-74.

PMID:
9120547
44.
45.

Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors.

Sipos EP, Tyler B, Piantadosi S, Burger PC, Brem H.

Cancer Chemother Pharmacol. 1997;39(5):383-9.

PMID:
9054951
46.

In vivo accuracy testing and clinical experience with the ISG Viewing Wand.

Sipos EP, Tebo SA, Zinreich SJ, Long DM, Brem H.

Neurosurgery. 1996 Jul;39(1):194-202; discussion 202-4.

PMID:
8805161
47.
48.

New delivery systems for brain tumor therapy.

Sipos EP, Brem H.

Neurol Clin. 1995 Nov;13(4):813-25. Review.

PMID:
8583998
49.

The role of minocycline in the treatment of intracranial 9L glioma.

Weingart JD, Sipos EP, Brem H.

J Neurosurg. 1995 Apr;82(4):635-40.

PMID:
7897527
50.

[Adverse effects of combined use of acenocoumarol and acetylsalicylic acid after myocardial infarct and unstable angina].

Sámóczi M, Farkas A, Sipos E, Tarján J.

Orv Hetil. 1995 Jan 22;136(4):177-9. Hungarian.

PMID:
7870411

Supplemental Content

Support Center